Business » Industry

Updated: January 12, 2014 03:12 IST

Dr. Reddy’s to market Optidoz, an anti-hypertension drug

Special Correspondent
Comment (2)   ·   print   ·   T  T  
The Hindu

Dr. Reddy’s Laboratories has announced that its drug Optidoz, for the treatment of hypertension, has been approved and is available for the Indian market. The drug will contribute to over Rs.100 crore revenue in 5-10 years, according to Alok Sonig, Senior Vice-President, India Businesss, Generics, Dr. Reddy’s.

Mr. Sonig, after launching the drug in Hyderabad, said, “the unique drug will address the needs of over 70 million people and will be a significant game changer in the domain of hypertension”.

It also saves Rs.10 per tablet to patients, according to him.


Optidoz is a single pill combination of three drugs — Amlodipine, Telmisartan and Hydrochrothiazide — with optimal dose of individual drugs. A pack of 10 tablets is priced at Rs.80.

The company claims that the drug controls hypertension faster with lesser side effects compared to double dose combinations.

More In: Industry | Business

The drug should get USFD approval soon for universal acceptance.It will be great boon to the mankind.Well done Dr.Reddys Garu

from:  M.Jambunathan
Posted on: Jan 13, 2014 at 00:24 IST

its really a tremendous achievement done by any other Indian Pharmaceutical company in hypertension management

from:  rasmiranjan
Posted on: Jan 12, 2014 at 19:56 IST
This article is closed for comments.
Please Email the Editor

Commodity prices

Take a look at the prices of various commodities in Chennai here»






Recent Article in Industry

A man uses an Apple iPhone near the advertisement of Samsung Electronics' micro SD cards at a Samsung shop in Seoul, South Korea. File photo

Battle of the big phones- Samsung down in China, Apple gains

Samsung lost the battle of the big phones last quarter as Apple’s copycat large iPhone lured buyers in the crucial Chinese market. ... »